News
4d
The Brighterside of News on MSNFDA-approved drug triples vaping quit rates in teens and young adultsA new clinical study, published in the journal JAMA, has revealed a powerful tool in the fight against teen and young adult ...
The drug varenicline, paired with counseling and text messaging support, helped teens and young adults abstain from vaping in a clinical trial.
The usual treatment that's used to stop youths from vaping is counseling. But adding medication and a supportive text messaging app helped more than half of people ages 16 to 25 quit, the study found.
The trial, published in JAMA, found that those who took varenicline were more than three times as likely to stop vaping compared to those who received counseling alone. Vaping has become the most ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results